You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

trastuzumab

( trass-TOO-zoo-mab )
Funding:
Evidence Building Program
  • Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer Supplemental
  • Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer
New Drug Funding Program
  • Trastuzumab - Gastric Cancer
  • Trastuzumab in Combination with Paclitaxel - Metastatic Breast Cancer
  • Trastuzumab - Second Line - Metastatic Breast Cancer
  • Trastuzumab - Single Agent - Metastatic Breast Cancer
  • Trastuzumab - Adjuvant Treatment for HER2_neu-Overexpressing Primary Breast Cancer
  • Trastuzumab in Combination with Vinorelbine - Metastatic Breast Cancer
  • Trastuzumab in Combination with Docetaxel - Metastatic Breast Cancer
Other Name(s): Herceptin® (Hoffmann-La Roche)
Appearance: Clear, colourless solution mixed into larger bags of fluids

You might also be interested in